Gilead argues this hide-and-seek approach is unnecessary, because the FDA interpretation is not binding.

FORBES: Gilead Challenges FDA Over Exclusivity For Its Latest AIDS Drug

Given that the letter represents an interpretation of federal law by major federal agencies, most colleges will regard it as binding.

WSJ: Greg Lukianoff: Feds to Students: You Can't Say That